about
Functional and phenotypical comparison of myofibroblasts derived from biopsies and bronchoalveolar lavage in mild asthma and sclerodermaThe extracellular matrix - the under-recognized element in lung disease?Versican in inflammation and tissue remodeling: the impact on lung disordersProteomics -- the protein expression technology to study connective tissue biology.A proteomic approach to mimic fibrosis disease evolvement by an in vitro cell line.Activation of platelet-derived growth factor pathway in human asthmatic pulmonary-derived mesenchymal cells.Proteomic 2DE database for spot selection, automated annotation, and data analysis.Specific haptoglobin expression in bronchoalveolar lavage during differentiation of circulating fibroblast progenitor cells in mild asthma.Correlation between airway responsiveness and proteoglycan production by bronchial fibroblasts from normal and asthmatic subjects.Biglycan isoforms with differences in polysaccharide substitution and core protein in human lung fibroblasts.Proteoglycan and proteome profiling of central human pulmonary fibrotic tissue utilizing miniaturized sample preparation: a feasibility study.Tumour necrosis factor-alpha interacts with biglycan and decorin.2DDB - a bioinformatics solution for analysis of quantitative proteomics data.Lung fibroblast clones from normal and fibrotic subjects differ in hyaluronan and decorin production and rate of proliferation.Proteome annotations and identifications of the human pulmonary fibroblast.Proteoglycan production in disomic and trisomy 7-carrying human synovial cells.Quantitative proteomic analysis of fibroblast nuclear proteins after stimulation with mitogen activated protein kinase inhibiting heparan sulfate.Biglycan and decorin induce morphological and cytoskeletal changes involving signalling by the small GTPases RhoA and Rac1 resulting in lung fibroblast migration.Nanocapillary liquid chromatography interfaced to tandem matrix-assisted laser desorption/ionization and electrospray ionization-mass spectrometry: mapping the nuclear proteome of human fibroblasts.Regulation of the chondroitin/dermatan fine structure by transforming growth factor-beta1 through effects on polymer-modifying enzymes.Tissue fibrocytes in patients with mild asthma: a possible link to thickness of reticular basement membrane?The importance of fibroblasts in remodelling of the human uterine cervix during pregnancy and parturition.Altered fibroblast proteoglycan production in COPD.Early extracellular matrix changes are associated with later development of bronchiolitis obliterans syndrome after lung transplantation.Relationship between matrix production by bronchial fibroblasts and lung function and AHR in asthma.Controlled and uncontrolled asthma display distinct alveolar tissue matrix compositions.TGFβ-induced matrix production by bronchial fibroblasts in asthma: budesonide and formoterol effects.Altered expression of small proteoglycans, collagen, and transforming growth factor-beta 1 in developing bleomycin-induced pulmonary fibrosis in rats.Enhanced ROCK1 dependent contractility in fibroblast from chronic obstructive pulmonary disease patients.Differential expressions of mRNA for proteoglycans, collagens and transforming growth factor-beta in the human cervix during pregnancy and involution.Defective alterations in the collagen network to prostacyclin in COPD lung fibroblasts.Specific subsets of mesenchymal stroma cells to treat lung disorders--finding the Holy Grail.Activated MCTC mast cells infiltrate diseased lung areas in cystic fibrosis and idiopathic pulmonary fibrosis.Disubstituted naphthyl β-D-xylopyranosides: Synthesis, GAG priming, and histone acetyltransferase (HAT) inhibition.Innate Immune Responses after Airway Epithelial Stimulation with Mycobacterium bovis Bacille-Calmette Guérin.The Respiratory Pathogen Moraxella catarrhalis Targets Collagen for Maximal Adherence to Host Tissues.Aberrant nonfibrotic parenchyma in idiopathic pulmonary fibrosis is correlated with decreased β-catenin inhibition and increased Wnt5a/b interaction.5-HT2B receptor antagonists attenuate myofibroblast differentiation and subsequent fibrotic responses in vitro and in vivo.Versican accumulates in vascular lesions in pulmonary arterial hypertension.Fibrocytes are associated with vascular and parenchymal remodelling in patients with obliterative bronchiolitis
P50
Q25255751-00425DBF-A05E-4DB5-A42B-09B06B08CF11Q28075842-60DF5086-10D5-4951-AE06-851A7CC9885AQ28250984-E4F4A8C4-C9F7-4CA0-8416-9A3059AF5EEDQ30658415-121541AD-5124-437A-BFB3-462E5A84480FQ30682172-DAB41725-5B39-4F0E-B7F5-D3BC41D6C9F5Q30724792-70A737A3-5A7F-4D35-85BF-71DD1E138D5FQ30769133-AD4D2B8C-E21C-423C-B793-7A6ADD727584Q30817028-FB9489A1-944E-4D5D-9D4D-ADAAEC3F4072Q30837858-C8032673-2772-4D25-8E2B-805485D222AAQ30840410-4FD581E0-B138-4B14-8236-F55C8968FE17Q30841232-B50C2D28-0A98-401A-9AD7-61512AB5939FQ30864778-1B12F77D-23B2-4A34-877C-A86112986E9CQ31034713-8608EE6A-EB9B-4D99-B817-03D33C198EF4Q31062066-917363B0-489D-4799-8D9F-116E41B478EFQ31093557-57591447-D853-4BA6-AAF8-D981725B9DB0Q31097295-9B37EC57-9E3F-4E8F-A487-12A793DC362BQ31141617-0CF58857-983E-41A5-A826-1096B6FF0352Q33194565-9DD8FD61-A1B7-4798-A73F-70A424A617D3Q33194964-B9E9A3FA-488B-4EE3-9567-8B630B799D49Q33222163-081112AC-BC28-4BE1-9670-A26AB6368A32Q33237943-8AAB54F0-1384-4778-B8E6-23EF88574F88Q33276802-EA815057-D49C-4F61-9C9B-51F207010EBCQ33575567-07242D2D-CB1A-4CF9-BAFB-ABD3F4D9700AQ33622446-6CE186E8-1803-4708-9FA0-76D344BE8700Q33634834-F2F5FD3A-7C3B-4F58-892A-DE76724F5068Q33874172-79473BED-977B-4492-ABB2-090B9879726AQ33880176-C00AE048-BD41-4C3C-8757-A41BAF0EF050Q34170199-B2E8941B-12F0-4697-8B61-5623014EE69CQ34389888-68B283C1-E78C-48AB-B937-56C297B8F5CAQ34466832-99349772-EAFA-4F79-915D-223F7EB56DBAQ34585087-BD3CB922-FA2A-4E27-A7E0-566E2172F207Q35266334-5A475783-BBDB-4A4F-91F4-CA1E7CA49CA1Q35531817-41A11B86-5F1F-4B6C-894E-0B9504F10F13Q35973008-42BE8F8A-4FAB-43FC-8B60-3324553E56FEQ36159388-460B0FAF-E982-4E09-BC11-7616CF4C6D82Q36727632-FFD84088-4628-47D0-ABF1-CC684B834162Q36773752-CBE41BF9-2117-4028-9CBD-A5854EBC066EQ37176705-CACABDE6-EF8B-4E72-B688-959A4F03075FQ37248333-580C8989-94E4-4BE9-8F72-4ABE0AAB7685Q37414229-3D7D1294-63B7-412C-AF7D-1EED4FCE3B20
P50
description
Swedish researcher
@en
Zweeds onderzoekster
@nl
svensk forsker
@nb
taighdeoir Sualannach
@ga
name
Gunilla Westergren-Thorsson
@ast
Gunilla Westergren-Thorsson
@da
Gunilla Westergren-Thorsson
@de
Gunilla Westergren-Thorsson
@en
Gunilla Westergren-Thorsson
@es
Gunilla Westergren-Thorsson
@fr
Gunilla Westergren-Thorsson
@ga
Gunilla Westergren-Thorsson
@nb
Gunilla Westergren-Thorsson
@nl
Gunilla Westergren-Thorsson
@nn
type
label
Gunilla Westergren-Thorsson
@ast
Gunilla Westergren-Thorsson
@da
Gunilla Westergren-Thorsson
@de
Gunilla Westergren-Thorsson
@en
Gunilla Westergren-Thorsson
@es
Gunilla Westergren-Thorsson
@fr
Gunilla Westergren-Thorsson
@ga
Gunilla Westergren-Thorsson
@nb
Gunilla Westergren-Thorsson
@nl
Gunilla Westergren-Thorsson
@nn
prefLabel
Gunilla Westergren-Thorsson
@ast
Gunilla Westergren-Thorsson
@da
Gunilla Westergren-Thorsson
@de
Gunilla Westergren-Thorsson
@en
Gunilla Westergren-Thorsson
@es
Gunilla Westergren-Thorsson
@fr
Gunilla Westergren-Thorsson
@ga
Gunilla Westergren-Thorsson
@nb
Gunilla Westergren-Thorsson
@nl
Gunilla Westergren-Thorsson
@nn
P214
P5587
P906
P106
P21
P214
P27
P31
P496
0000-0001-5327-8805
P5587
75kmn6sr0shk03l
P569
1962-01-01T00:00:00Z
P7859
viaf-59054880